To investigate whether it is possible to predict successful remission-induction by anti-TNFα treatment in IBD patients based on pre-treatment mucosa biopsy analysis, pre-treatment data from CD, CDc and CDi subtype (GSE16879; GSE527460) and UC (GSE16879, GSE23597) patients were analyzed. This evidence concerns the gene TNF and inflammatory bowel disease.